Market Overview

Imperva Sold In $2.1B Go-Private Deal; Cybersecurity Stocks Trade Down

Share:
Imperva Sold In $2.1B Go-Private Deal; Cybersecurity Stocks Trade Down

Cybersecurity provider Imperva Inc (NASDAQ: IMPV) agreed Wednesday morning to sell itself to private equity firm Thoma Bravo for an approximate 30-percent premium.

What Happened

The deal prices Imperva at $55.75 per share; the stock closed at $43 Tuesday. The sale values Imperva at around $2.1 billion, but failed to offer support to other cybersecurity stocks. The group was trading lower Wednesday: 

  • Fortinet Inc (NASDAQ: FTNT): was down 4.87 percent at the time of publication. 
  • FireEye Inc (NASDAQ: FEYE): was down 2.52 percent.
  • Palo Alto Networks Inc (NYSE: PANW): was down 3.56 percent.
  • Cyberark Software Ltd (NASDAQ: CYBR): was down 3.14 percent.

Why It's Important

As a private entity, Imperva will be better-positioned to "focus on execution and drive to be a world-class profitable growth company," it said in a statement. The deal offers investors "immediate and substantial value," according to the cybersecurity company. 

What's Next

Imperva's technology will remain vital in protecting the overall digital economy at a time when software applications and data are "increasingly under cyberattack," Thoma Bravo partner Chip Virnig said in a statement.

The private equity firm's expertise and track record within the cybersecurity space "fits squarely" with the company's long-term objectives, according to the deal announcement. 

The transaction is expected to close in the fourth quarter of 2018 or earlier and includes a 45-day "go-shop" period where Imperva can actively explore and evaluate competing acquisition offers.

Related Links:

BTIG Downgrades Zscaler On Valuation, Says Company Is Redefining Cybersecurity Market

Cyberark Among The Few 'Reasonably Priced' Software Stocks, JPMorgan Says In Upgrade

 

Related Articles (IMPV)

View Comments and Join the Discussion!

Posted-In: cloud Cybersecurity thoma bravoM&A News Best of Benzinga